Clinical Trial Update: Pressure Enabled Intrapancreatic Delivery of SD-101 With Checkpoint Blockade for Locally Advanced Pancreatic Adenocarcinoma [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates pressure-enabled intrapancreatic delivery of SD-101 in combination with checkpoint blockade for locally advanced pancreatic adenoca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• SD-101

Snippet

Sponsor: TriSalus Life Sciences, Inc. | Conditions: Locally Advanced Pancreatic Adenocarcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING